- Zota Health Care Ltd
- ZOTA (NSE)
Zota Health Care Limited is an India-based company, which is engaged in drug development, manufacturing and marketing. The Company offers a portfolio consisting of a range of pharmaceutical, nutraceutical, as well as ayurvedic products in India and abroad. Its domestic products include Acarbose 25/50 mg, Aceclofenac 100 mg + Paracetamol 325 mg, Aceclofenac 100 mg , Aceclofenac 200 mg SR, Albendazole 400 mg + Ivermectin 6 mg, Amilsupride 50/100/200 mg, Amitriptyline HCL 10/25 mg, and others. Its imternational products include Artemether 20/80 MG + Lumifentine 120/480 mg, Atenolol 50/100 mg, Atorvastatin 10 mg + Fenofibrate 160 mg Tab, Atorvastatin 10/20/40 mg Tab, Betahistine 16 mg Tab, Bromhexine 8 mg, Calcium 500 mg + Vit D3 250 IU, Carbamazepine 200 mg, Cetrizine 10 mg, Chlorpheniramine Maleate 4 mg, Cimetidine 200/400 mg, Citicoline 500 mg, Clopidogrel 75 mg, Clozapine 100 mg, Desloratidine 5 mg, Domperidone 10 mg DT, Escitalopram 10 mg, Finasteride 5mg, and others.
Disclaimer : All estimates (1 year forward) are based on Consensus View provided by Refinitiv.